These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22374422)

  • 1. Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.
    Bi XC; Liu JM; He HC; Ye YK; Han ZD; Dai QS; Liang YX; Cai C; Chen JH; Chen XB; Qin GQ; Zeng GH; Zhong WD
    Clin Transl Oncol; 2012 Mar; 14(3):190-6. PubMed ID: 22374422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.
    Zhang C; Tu Z; Du S; Wang Y; Wang Q
    Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma.
    Chu T; Chen X; Yu J; Xiao J; Fu Z
    Pathol Oncol Res; 2011 Sep; 17(3):705-11. PubMed ID: 21448785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.
    Chen T; Zhu J
    Med Oncol; 2010 Dec; 27(4):1185-91. PubMed ID: 19921476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
    Sienel W; Polzer B; Elshawi K; Lindner M; Morresi-Hauf A; Vay C; Eder F; Passlick B; Klein CA
    Mod Pathol; 2008 Sep; 21(9):1130-8. PubMed ID: 18567995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
    J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
    Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
    Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features.
    Tickoo SK; Hutchinson B; Bacik J; Mazumdar M; Motzer RJ; Bajorin DF; Bosl GJ; Reuter VE
    Int J Surg Pathol; 2002 Jan; 10(1):23-32. PubMed ID: 11927966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.
    Tian L; Zhang Y; Chen Y; Cai M; Dong H; Xiong L
    PLoS One; 2013; 8(3):e58069. PubMed ID: 23516431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
    Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
    Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.
    Bi XC; Liu JM; Zheng XG; Xian ZY; Feng ZW; Lou YX; Zhong WD; Wu CL
    Clin Invest Med; 2011 Dec; 34(6):E358. PubMed ID: 22129926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
    Boye K; Nesland JM; Sandstad B; Haugland Haugen M; Mælandsmo GM; Flatmark K
    Br J Cancer; 2012 Aug; 107(4):667-74. PubMed ID: 22782346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
    Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
    Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically atypical seminomas with yolk sac tumor features.
    Som A; Xiao L; Zhu R; Guo CC; Xiao L; Rao P; Efstathiou E; Matin A; Tu SM
    Can J Urol; 2013 Aug; 20(4):6860-7. PubMed ID: 23930614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
    Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
    Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methyltransferase 3B expression is associated with poor outcome of stage I testicular seminoma.
    Arai E; Nakagawa T; Wakai-Ushijima S; Fujimoto H; Kanai Y
    Histopathology; 2012 May; 60(6B):E12-8. PubMed ID: 22394436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GOLPH2 expression may serve as diagnostic marker in seminomas.
    Fritzsche FR; Kristiansen G; Riener MO; Dietel M; Oelrich B
    BMC Urol; 2010 Feb; 10():4. PubMed ID: 20184749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of emmprin and monocarboxylate transporter-1 in ovarian epithelial tumors.
    Fukuoka M; Hamasaki M; Koga K; Hayashi H; Aoki M; Kawarabayashi T; Miyamoto S; Nabeshima K
    Virchows Arch; 2012 Oct; 461(4):457-66. PubMed ID: 22926487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.
    Futamura N; Nishida Y; Urakawa H; Kozawa E; Ikuta K; Hamada S; Ishiguro N
    Tumour Biol; 2014 Jun; 35(6):5159-65. PubMed ID: 24481662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.